OTC · Medical - Devices

BICO Group AB (publ) (CLLKF) Stock

$1.53 +0.00% OTC: CLLKF Healthcare

BICO Group AB (publ) is a global bio-convergence enterprise, conducting operations across North America, Europe, Asia, and other international markets. Its business is structured into two main divisions: Laboratory Solutions and Bioautomation.

Valuation

MetricValue
Price$1.53
Market Cap$105.68M
P/E Ratio-1.07
P/B Ratio0.65
P/S Ratio0.69
EPS (TTM)$-15.40
52-Week High$3.77
52-Week Low$1.52
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-51.81%
ROA-33.20%
ROCE-10.08%
Gross Margin44.96%
Operating Margin-16.32%
Net Margin-66.09%
Debt/Equity0.43
Current Ratio2.35

Annual Financials (USD)

Metric20202021202220242025
Revenue$177.0M$1.3B$2.2B$1.9B$1.5B
Operating Profit$-66.0M$-237.0M$-997.0M$-289.0M$-251.0M
Net Profit$-62.0M$-228.0M$-833.0M$-5.0M$-1.1B
EPS$-1.47$-3.71$-12.45$-0.01$-15.40
Op Margin-37.4%-18.8%-44.5%-14.8%-16.8%

Balance Sheet (USD)

Metric20202021202220242025
Total Assets$1.6B$9.8B$10.2B$5.5B$3.7B
Total Liabilities$127.0M$3.0B$3.3B$2.5B$1.9B
Cash$809.0M$481.0M$925.0M$598.0M$1.3B
Borrowings$62.0M$1.6B$1.9B$1.8B$1.5B

Cash Flow (USD)

Metric20202021202220242025
Operating Cash Flow$-72.0M$-409.0M$-269.0M$158.0M$68.0M
Investing Cash Flow$-352.0M$-4.9B$-572.0M$84.0M$693.0M
Financing Cash Flow$-41.0M$-135.0M$-81.0M$3.0M$-107.0M
Net Cash Flow$769.0M$46.0M$444.0M$85.0M$494.0M
Free Cash Flow$-154.0M$-676.0M$-799.0M$114.0M$55.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.92
FCF Yield2.35%
Quick Ratio1.99
Interest Coverage-1.42
Return 1Y-61.28%
Return 3Y-64.42%
Return 5Y—

Ownership

Insiders Held30.01%
Institutions Held22.21%
Institutions Float Held31.74%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BICO Group AB (publ)

BICO Group AB (publ) is a global bio-convergence enterprise, conducting operations across North America, Europe, Asia, and other international markets. Its business is structured into two main divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions segment delivers a range of advanced equipment, including 3D bioprinters, hybrid microscopy systems, single-cell dispensing instruments, and liquid handling devices. This division also supplies essential consumables such as bioinks, reagents, microscope lenses, software, printheads, and even 3D reconstructed human tissues, particularly for applications in regulatory testing. Furthermore, Laboratory Solutions offers specialized services like 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology, primarily serving pharmaceutical and biotechnology companies. Conversely, the Bioautomation segment caters to industrial customers with products focused on precision dispensing and innovative biosensor technology. It also provides sophisticated diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. Overall, BICO Group's offerings include comprehensive solutions for industrial ecosystems, tissue engineering, multi-omics analysis, cell line development, and diagnostics. Its primary clientele originates from the medical, pharmaceutical, and cosmetic sectors. Founded in 2016 and headquartered in Gothenburg, Sweden, the company was previously known as Cellink AB (publ) before officially changing its name to BICO Group AB (publ) in August 2021.

BICO Group AB (publ) is headquartered in SE.

BICO Group AB (publ) (CLLKF) stock trades at $1.53 with a market capitalization of $105.68M. The stock is valued at a price-to-earnings (P/E) ratio of -1.07, price-to-book of 0.65, price-to-sales of 0.69. Over the past 52 weeks the stock has ranged between $1.52 and $3.77, and currently trades 59.4% below its 52-week high.

On profitability, BICO Group AB (publ) generates a return on equity (ROE) of -51.81%, return on capital employed of -10.08%, an operating margin of -16.32%, a net profit margin of -66.09%.

Official website: www.bico.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides